Repatha RAS layoffs

anonymous · Sep 6, 2019 at 11:32 AM

anonymous said: ↑

The RAS position isn’t needed with a drug that no longer requires specialty pharmacy. The process is complicated because the office is lazy and doesn’t want to complete paperwork and because Amgen didn’t secure coverage from day one. Now that it is filled at the local pharmacy, it makes it similar to every other primary care drug on the market with the addition of the higher price tag, and the lack of insurance coverage. Amgen went for commercial plans and should have known from day one this is a Medicare part D drug.
The RAS position took pressure off the BSR and office, but is no way the same caliber as other reimbursement positions that do buy and bill. Most were previous sales reps with very little experience if any in reimbursement or even knew how to read a patient chart.Amgen “leaders” screwed everyone with their greed, arrogance, and incompetence. I wish the RAS and Repatha nurses the best in finding a reputable company with decent leadership next go around. The writing was on the wall, and us BSRs are next on the list to go. Too much overhead not enough profit.
Click to expand...

Useful Searches

Repatha RAS layoffs

anonymous Guest